Emcure Pharmaceuticals reported a strong finish to the fiscal year, with Q4 profit showing a 24 percent year-on-year rise in net profit to Rs 243.74 crore. The company’s latest earnings highlight steady business momentum driven by solid demand...
OneSource partners have secured Canada approval, generic semaglutide injection, a major step that could make diabetes treatment more affordable while boosting competition in the rapidly growing GLP-1 drug market.
Takeda Pharmaceutical Company reported new data today showing its Takeda immune drug TAK-881 performs as effectively as an already approved treatment in patients with primary immunodeficiency (PID).
RPG Life Sciences is sharpening its strategy today with a strong focus on its GLP-1 entry plan and expanding API business, signaling a shift toward high-growth pharmaceutical segments. The company is looking to strengthen its position in active...
Granules India reported a strong finish to FY26, with Granules India Q4 profit rising 33 percent year-on-year to Rs 201 crore. The company’s performance reflects solid demand, improved margins, and steady execution across key business segments.
Artificial intelligence-focused biotech company Profluent has partnered with pharmaceutical major Eli Lilly and Company in a genetic medicine deal worth up to $2.25 billion. The collaboration aims to develop advanced gene-editing therapi...
Akums Drugs & Pharmaceuticals Limited has announced the launch of Aztreonam-Avibactam Injection, a new antibiotic therapy designed to tackle multidrug-resistant gram-negative bacterial infections. The move comes at a time when rising...
India’s Sun Pharmaceutical Industries has announced a major Sun Pharma Organon acquisition, agreeing to buy U.S.-based Organon & Co. in an all-cash deal valued at USD 11.75 billion, including debt. The company will pay USD 14 per share to acquire...
Shares of Alembic Pharmaceuticals edged up 1.09 percent to Rs 772.55 after the company revealed plans to strengthen its global footprint with a new subsidiary in Southeast Asia. The move signals Alembic Pharmaceuticals’ continued push into...
Amneal Pharmaceuticals has announced a major acquisition deal worth up to $1.1 billion acquisition to acquire Kashiv BioSciences, strengthening its presence in the fast-growing biosimilars market. The move reflects the increasing focus among pharm...
, CDSCO.jpg)